GKV system under pressure: Pharma Germany demands profound reforms

In a dramatic appeal, Pharma Germany raises his voice! Two years after the entry into force of the GKV Finance Stabilization Act, a worrying image becomes clear: The statutory health insurance system (GKV) is faced with a huge test, due to non-insurance services, which are accompanied by the new hospital reform. Dorothee Brakmann, the managing director of the organization, raises the alarm: "The challenges for our solidarity systems are enormous in view of the demographic development."

Why is that so important? Brakmann is convinced that these additional loads cannot be mastered through measures such as the transformation fund and that relief for the GKV system is urgently needed. Instead of being confronted with ever new loads, the funds from tax funds should come, they urge it.

The pressing request for personal responsibility

An innovative approach could be the strengthening of the personal responsibility of the insured. Brakmann suggests that further substances are released from the prescription obligation. "This could bring the GKV system over one billion euros in savings," said her statement. A hearty stumbling block for the GKV budget pressure, which would not only strengthen pharmacies, but also enables the insured person to access proven drugs faster and relieve the entire health system.

But that's not all! There are more to note: The costly pressure on prescription generics could also be reduced by these measures. "Additional burdens of the GKV system due to non-insurance services are the wrong way," warns Brakmann. "These have direct effects on health care in other important areas." A risk for patients not to be underestimated!

social responsibility

Pharma Germany demands a clear turn: The responsibility for the financing of the social security systems must be supported in terms of society as a whole. This is the only way to ensure the quality of health care in the long term.

summarized: The future of the GKV system is on the brink! It is up to society to find solutions that both ensure medical care and overcome the serious financial challenges. Who will take responsibility? The clock ticks!

der Pharma Deutschland e.V. is the highest membership association of the pharmaceutical industry in Germany and represents around 400 member companies that employ around 80,000 employees in Germany. They make a decisive contribution to the supply of drugs in Germany and provide almost 80 percent of the over -the -counter -free -free and almost two thirds of the prescription medicines. Further information is available at www.pharmadeutschland.de.